Austria: drug-related information and data
Austria
Our partner in Austria
Gesundheit Österreich GmbH (GÖG)
Stubenring 6
A-1010 Wien
Tel. +43 15156160
Fax +43 15138472
Head of Focal Point: Ms Marion Weigl
The Austrian National Focal Point is located within the Gesundheit Österreich GmbH (GÖG), an NGO funded by the Ministry of Health. The GÖG has three business units, carrying out research, planning, monitoring and reporting activities (within the business unit ÖBIG), developing, implementing and evaluating a nationwide quality system for health care (within the business unit BIQG) as well as promoting and financing of health promotion activities (within the business unit FGÖ). The Austrian National Focal Point is located within the working area prevention in the business unit ÖBIG.E-mail addresses have been inserted in a way discouraging spam. Please replace [a] by @ before actually using any of the e-mail addresses.
Country situation summaries are written with the general reader in mind and provide short, mainly text-based analyses of national drug situations.
Key data sheets provide an at-a-glance statistical view of the drug situation by country and cover areas including prevalence, problem drug use, infectious diseases, deaths, and more.
Country barometers provide a graphical representation of drug use prevalence data for each country, showing its position relative to other countries by population and drug.
What are countries in Europe doing to prevent illicit drug use? 'Prevention profiles' attempts to answer this question using interactive maps and data charts based on expert appraisals.
Legal profiles describe national drug-related legislation in a standardised, comparable format. Topics covered include possession, trafficking, classification, prosecution, prevention, treatment, among others.
This resource provides access to the current national strategies and action plans for each country as well as a brief description of recent and ongoing work in the area.
Each treatment profile provides information on the national context, treatment registries and monitoring systems, treatment demand, availability of treatment services as well as references and resources.
Each overview describes: the national context; references and resources; key responses for preventing and reducing drug-related infectious diseases and; drug-related deaths and drug-related harms in recreational settings.
These data sheets on drug-related public expenditure cover 30 countries and examine how much countries spend on drug-related activities, whether there are specific budgets allocated to drug policy documents, and how drug-related expenditure has evolved over time.
National reports draw an overall picture of the drug phenomenon at national level. The data is an important resource, among others for the compilation of the EMCDDA's Annual report.
National drug related research provides information by country in the following areas: main funding frameworks, research institutions, scientific journals, websites, main studies conducted and articles published.
